REPH - Recro Pharma, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5170.96M
Enterprise Value 3145.43M
Trailing P/E -4.22
Forward P/E 1-3.46
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.44
Price/Book (mrq)3.00
Enterprise Value/Revenue 32.08
Enterprise Value/EBITDA 6-11.15

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profit Margin -46.75%
Operating Margin (ttm)-29.33%
Management Effectiveness
Return on Assets (ttm)-8.46%
Return on Equity (ttm)-74.12%
Income Statement
Revenue (ttm)69.99M
Revenue Per Share (ttm)4.50
Quarterly Revenue Growth (yoy)-2.00%
Gross Profit (ttm)32.19M
EBITDA -13.04M
Net Income Avi to Common (ttm)-32.72M
Diluted EPS (ttm)-2.12
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)50.24M
Total Cash Per Share (mrq)2.64
Total Debt (mrq)24.71M
Total Debt/Equity (mrq)43.37
Current Ratio (mrq)5.80
Book Value Per Share (mrq)2.99
Cash Flow Statement
Operating Cash Flow (ttm)-8.79M
Levered Free Cash Flow (ttm)-5.84M

Trading Information

Stock Price History
Beta -1.18
52-Week Change 318.07%
S&P500 52-Week Change 319.09%
52 Week High 310.17
52 Week Low 35.81
50-Day Moving Average 38.52
200-Day Moving Average 37.76
Share Statistics
Avg Vol (3 month) 382.35k
Avg Vol (10 day) 395.8k
Shares Outstanding 519.06M
Float 7.75M
% Held by Insiders 17.65%
% Held by Institutions 182.10%
Shares Short 3813.62k
Short Ratio 39.7
Short % of Float 310.40%
Shares Short (prior month) 3891.63k
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A